| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2804674 | Journal of Diabetes and its Complications | 2007 | 6 Pages |
Abstract
Rosiglitazone+insulin combination is safe and effective in inadequately controlled insulin-treated T2DM patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Ranjna Garg, Jayanthi Gopal, Geraint Rhys Jones,